Notice2026-02669

Center for Scientific Review; Notice of Closed Meetings

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
February 11, 2026

Issuing agencies

Health and Human Services DepartmentNational Institutes of Health

Full Text

<html>
<head>
<title>Federal Register, Volume 91 Issue 28 (Wednesday, February 11, 2026)</title>
</head>
<body><pre>
[Federal Register Volume 91, Number 28 (Wednesday, February 11, 2026)]
[Notices]
[Pages 6231-6232]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2026-02669]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Notice of Closed Meetings

    Pursuant to section 1009 of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Fellowships: Risk, Prevention, and Health Behavior.
    Date: March 11-12, 2026.
    Time: 9:00 a.m. to 5:30 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Trina Colleen Salm Ward, Ph.D., Scientific 
Review Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 594-5254, 
<a href="/cdn-cgi/l/email-protection#3b485a57564c5a495f4f587b58484915555253155c544d"><span class="__cf_email__" data-cfemail="c4b7a5a8a9b3a5b6a0b0a784a7b7b6eaaaadaceaa3abb2">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; Career Development K Awards: Clinical Scientists, 
Bioengineering, Surgery and Imaging.
    Date: March 11, 2026.
    Time: 10:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Evon Sami Abisaid, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, Bethesda, MD 20892, (227) 259-7968, <a href="/cdn-cgi/l/email-protection#fa9f8c9594d49b9893899b939eba949392d49d958c"><span class="__cf_email__" data-cfemail="ddb8abb2b3f3bcbfb4aebcb4b99db3b4b5f3bab2ab">[email&#160;protected]</span></a>.

    Name of Committee: Center for Scientific Review Special Emphasis 
Panel; PAR-23-242: NCI Research Specialist (Laboratory-based 
Scientist) Award (R50).
    Date: March 11, 2026.
    Time: 11:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Bruce Daniel Hissong, Ph.D., Scientific Review 
Officer, Cancer Therapeutics Branch, Division of Translational and 
Clinical Sciences, Center for Scientific Review, National Institutes 
of Health, 6701 Rockledge Drive, Rm. 806E, Bethesda, MD 20892, (240) 
276-7752, <a href="/cdn-cgi/l/email-protection#88eafafdebeda6e0e1fbfbe7e6efc8e6e1e0a6efe7fe"><span class="__cf_email__" data-cfemail="4426363127216a2c2d37372b2a23042a2d2c6a232b32">[email&#160;protected]</span></a>.

    Name of Committee: Bioengineering Sciences & Technologies 
Integrated Review Group; Drug and Biologic Therapeutic Delivery 
Study Section.
    Date: March 16-17, 2026.
    Time: 9:00 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.

[[Page 6232]]

    Meeting Format: Virtual Meeting.
    Contact Person: Janice Duy, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Bethesda, MD 20892, (301) 594-3139, 
<a href="/cdn-cgi/l/email-protection#472d26292e24226923323e07292e2f69202831"><span class="__cf_email__" data-cfemail="c6aca7a8afa5a3e8a2b3bf86a8afaee8a1a9b0">[email&#160;protected]</span></a>.

    Name of Committee: Interdisciplinary Molecular Sciences and 
Training Integrated Review Group; Enabling Bioanalytical and Imaging 
Technologies Study Section.
    Date: March 16-17, 2026.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, 6701 Rockledge Drive, 
Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Kenneth Ryan, Ph.D., Scientific Review Officer, 
Center for Scientific Review, National Institutes of Health, 6701 
Rockledge Drive, Room 3218, MSC 7717, Bethesda, MD 20892, 301-435-
0229, <a href="/cdn-cgi/l/email-protection#e388868d8d86978bcd919a828da38d8a8bcd8b8b90cd848c95"><span class="__cf_email__" data-cfemail="6f040a01010a1b07411d160e012f0106074107071c41080019">[email&#160;protected]</span></a>.

    Name of Committee: Risk, Prevention and Health Behavior 
Integrated Review Group; Biobehavioral Medicine and Health Outcomes 
Study Section.
    Date: March 16-17, 2026.
    Time: 9:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Address: National Institutes of Health, Rockledge II, 6701 
Rockledge Drive, Bethesda, MD 20892.
    Meeting Format: Virtual Meeting.
    Contact Person: Mark A. Vosvick, Ph.D., Scientific Review 
Officer, Center for Scientific Review, National Institutes of 
Health, 6701 Rockledge Drive, Room 3110, Bethesda, MD 20892, (301) 
402-4128, <a href="/cdn-cgi/l/email-protection#751814071e5b031a06031c161e351b1c1d5b121a03"><span class="__cf_email__" data-cfemail="93fef2e1f8bde5fce0e5faf0f8d3fdfafbbdf4fce5">[email&#160;protected]</span></a>.

(Catalogue of Federal Domestic Assistance Program Nos. 93.306, 
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, 
National Institutes of Health, HHS)

    Dated: February 6, 2026.
Bruce A. George,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2026-02669 Filed 2-10-26; 8:45 am]
BILLING CODE 4140-01-P


</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>
Indexed from Federal Register on February 11, 2026.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.